Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/1996
06/12/1996EP0715623A1 Platelet aggregation inhibitors
06/12/1996CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products
06/11/1996US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells
06/11/1996US5525629 Inhibition of cytokine production
06/11/1996US5525604 4-aminopyrimidine derivatives
06/11/1996US5525486 Genetic engineering
06/11/1996CA1338395C Pharmaceutical containing tissue protein pp4, a process for the pasteurization of pp4, and the use of pp4
06/06/1996WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination
06/06/1996WO1996016966A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
06/06/1996WO1996016940A1 Novel amidinonaphthyl derivative or salt thereof
06/06/1996WO1995032298A3 Safe vectors for gene therapy
06/05/1996EP0714982A2 Hybrid proteins with fibrinolytic and thrombin inhibiting activity
06/05/1996EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands
06/05/1996EP0714435A1 Pro-urokinase mutants
06/05/1996EP0714408A1 Tryptase inhibitor
06/05/1996EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity
06/05/1996EP0714299A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
06/05/1996EP0714295A1 Fibrinogen receptor antagonists
06/05/1996CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy
06/04/1996US5523492 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
06/04/1996US5523322 Method for inhibiting blood-platelet aggregration with β-naphthoquinone compounds
06/04/1996US5523308 Peptidyl heterocycles useful in the treatment of thrombin related disorders
06/04/1996US5523292 Method of preventing restenosis following coronary angioplasty
06/04/1996US5523287 Thrombin-inhibitory protein from assassin bugs
05/1996
05/31/1996CA2163925A1 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
05/30/1996WO1996015802A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
05/30/1996WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015795A1 Compositions containing lazaroids and their use for preventing adhesions
05/30/1996WO1996015758A2 Methods for stimulating erythropoiesis using thrombopoietin
05/30/1996DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation
05/29/1996EP0713881A2 Use of vWF containing concentrate as combination therapy with antithrombotics and fibrinolytics
05/29/1996EP0713496A1 Fibrin-targeted inhibitors of thrombin
05/29/1996EP0713495A1 Methods of enhancing bioactivity of chemokines
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0650364A4 Purification of factor ix.
05/29/1996CN1123168A Chinese medicine for curing aftereffect resulted from cerebral embolism
05/29/1996CN1123149A Quick-acting blood-coagulating preparation made from traditional Chinese medicine
05/29/1996CN1031879C Process for preparing ATP analogues
05/28/1996US5521213 Nonsteroid antiinflammatory agents
05/28/1996US5521206 Hypotensive agents, treatment of atherosclerosis
05/28/1996US5521070 DNA sequence coding for human factor IX or a similar protein, expression vector, transformed cells, method for preparing factor IX and corresponding products obtained
05/23/1996WO1996015229A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
05/23/1996WO1996015150A1 Process for purifying factor viii
05/23/1996WO1996015147A1 Human stanniocalcin-alpha
05/23/1996WO1996015140A1 Process for purification of factor viii
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996009827A3 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2203525A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
05/22/1996EP0712934A2 Proteins with fibrinolytic and anticoagulant activity
05/22/1996EP0712629A1 Acyl deoxyribonucleoside derivatives and uses thereof
05/22/1996EP0712626A2 Use of R,S-(+/-)-alpha-Lipoic acid, S-(-)-alpha-Lipoic acid in reduced or oxidized form or their metabolites as well as their salts, esters, amides for the manufacture of rheological agents
05/22/1996EP0712388A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect
05/21/1996US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them
05/21/1996US5519005 Guanidine terminated peptides for treatment of thrombosis, antitumor agents, autoimmune diseases and immunology
05/18/1996CA2162986A1 Proteins having fibrinolytic and coagulation-inhibiting properties
05/17/1996WO1996014425A1 Polysaccharides having a high iduronic acid content
05/17/1996WO1996014394A1 Human dna ligase iii
05/17/1996WO1996014084A1 A storage stable water solution for infusion containing a thrombin inhibitor
05/17/1996WO1996014082A1 Methods and kits using macrophage stimulating protein
05/17/1996CA2204366A1 Polysaccharides having a high iduronic acid content
05/17/1996CA2203396A1 A storage stable water solution for infusion containing a thrombin inhibitor
05/15/1996EP0711770A1 Antagonists of adhesion receptors
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0482013B1 Nonglycosylated human interleukin-3 analog proteins
05/15/1996EP0456835B1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
05/15/1996EP0343217B1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
05/15/1996CN1122573A Oxygen-reduced aqueous solution of factor VIII
05/15/1996CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid
05/14/1996US5516910 Ticlopidine intermediate
05/14/1996US5516781 Method of treating restenosis with rapamycin
05/14/1996US5516764 Anti-inflammatory agent
05/14/1996US5516685 Isolation and characterization of a novel protease from Streptomyces lividans
05/14/1996US5516675 Separation of lactoperoxidase, secretory component and lactoferrin from milk or whey with a cation exchange resin
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013583A2 Targeted hetero-association of recombinant proteins to multi-functional complexes
05/09/1996WO1996013492A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
05/09/1996WO1996013274A1 Process for production of inhibited forms of activated blood factors
05/09/1996DE4439477A1 Use of alpha-liponic acid, its isomers and derivs.
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203807A1 Process for production of inhibited forms of activated blood factors
05/09/1996CA2162223A1 Adhesion receptor antagonists
05/08/1996EP0710657A1 Antagonists of adhesion receptors
05/08/1996EP0710288A1 Adenoviral vectors for treatment of hemophilia
05/08/1996EP0710285A1 Analogues of an anti-thrombin polypeptide and process for their preparation
05/08/1996EP0710279A1 Yolk sac stem cells and their uses
05/08/1996EP0710247A1 Process for manufacture of 1-deamino-8-d-arginine vasopressin
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710115A1 Method for administering hemoglobin
05/08/1996EP0710114A1 A coagulation factor viii formulation
05/08/1996EP0710107A1 N,n,n-trimethylsphingosine derivatives
05/07/1996US5514780 Derivatives of human haemoglobin, method for preparing them, products derived therefrom and use of these derivatives and products
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514659 3-deoxy oligosaccharides and pharmaceutical compositions containing them
05/07/1996US5514536 Solutions for tissue preservation and bloodless surgery and methods using same
05/07/1996US5514409 Methods for coating invasive devices with inhibitors of thrombin
05/07/1996CA2025317C Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
05/02/1996WO1996012800A1 Modified factor vii
1 ... 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 ... 671